| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.37▲ | 1.38▼ | 1.37▲ | 1.26▲ | 1.23▲ |
| MA10 | 1.38▼ | 1.37▲ | 1.35▲ | 1.23▲ | 1.40▼ |
| MA20 | 1.38▼ | 1.34▲ | 1.30▲ | 1.20▲ | 1.29▲ |
| MA50 | 1.36▲ | 1.27▲ | 1.25▲ | 1.41▼ | 1.00▲ |
| MA100 | 1.34▲ | 1.24▲ | 1.21▲ | 1.28▲ | 1.10▲ |
| MA200 | 1.29▲ | 1.21▲ | 1.26▲ | 1.05▲ | 1.25▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.000▲ | 0.008▲ | 0.028▲ | -0.033▼ |
| RSI | 51.155▲ | 65.884▲ | 71.021▲ | 59.147▲ | 55.405▲ |
| STOCH | 26.389 | 89.438▲ | 85.218▲ | 71.148 | 21.400 |
| WILL %R | -60.000 | -13.636▲ | -8.824▲ | -12.000▲ | -60.674 |
| CCI | -31.293 | 40.329 | 79.100 | 264.026▲ | -34.188 |
|
Wednesday, November 05, 2025 07:55 AM
Ocugen (OCGN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.05 per share a year ago. These figures are ...
|
|
Tuesday, August 26, 2025 09:00 AM
Investors might want to bet on Ocugen (OCGN), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...
|
|
Friday, August 01, 2025 04:16 PM
Ocugen is focused on developing treatments for vision-threatening diseases. Its main focus is gene therapy, a technique that uses genetic material to treat or prevent disease. The company's lead gene ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/25 | 1.31 | 1.39 | 1.30 | 1.36 | 4,027,340 |
| 11/12/25 | 1.23 | 1.32 | 1.2174 | 1.30 | 3,983,408 |
| 10/12/25 | 1.205 | 1.25 | 1.19 | 1.23 | 3,169,596 |
| 09/12/25 | 1.20 | 1.22 | 1.19 | 1.21 | 2,590,500 |
| 08/12/25 | 1.23 | 1.25 | 1.18 | 1.20 | 2,675,300 |
| 05/12/25 | 1.24 | 1.26 | 1.22 | 1.22 | 2,350,730 |
| 04/12/25 | 1.21 | 1.255 | 1.195 | 1.24 | 3,252,900 |
| 03/12/25 | 1.16 | 1.21 | 1.14 | 1.21 | 4,600,400 |
| 02/12/25 | 1.19 | 1.20 | 1.155 | 1.16 | 2,951,500 |
| 01/12/25 | 1.25 | 1.255 | 1.18 | 1.18 | 3,190,700 |
|
|
||||
|
|
||||
|
|